Insider

Philip Morris International released its third-quarter 2026 results

Philip Morris International Inc. reported third-quarter 2026 financial results, with quarterly revenue of $11.4 billion. Revenue rose 5.5% year-over-year, while operating income reached $4.9 billion, up 14.1% from a year earlier.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Industrial building with large ventilation units outside
Photo by strelenka on Unsplash
$11.4 billion
Quarterly revenue
$3.3 billion
Quarterly net income
$1.60
Quarterly dividend

Key points

  • The company released its report for the third quarter ended September 30, 2026.
  • Operating cash flow for the first nine months of 2026 rose 38.8% to $10.4 billion compared to the same period a year earlier.
  • Operations in Russia and Ukraine, which accounted for 7% and 1% of net revenues respectively for the first nine months of 2026, carry risks including potential further impairment charges due to the conflict in Ukraine.

Quarterly financial results.

The company released its report for the third quarter ended September 30, 2026. Despite higher operating income, net income fell 4.7% to $3.3 billion, leading to a 4.9% decline in diluted earnings per share (EPS) to $2.12.

Quarter vs the same quarter a year earlier

Jul–Sep 2025Jul–Sep 2026Revenue+5.5%$10.8B$11.4BOperating income+14.1%$4.3B$4.9BNet income-4.7%$3.5B$3.3B
Data from the original sources listed alongside.

Operating activities and dividends.

Operating cash flow for the first nine months of 2026 rose 38.8% to $10.4 billion compared to the same period a year earlier. Capital expenditure remained nearly unchanged at $1.1 billion. In September 2026, the company's board of directors increased the regular quarterly dividend by 8.8% to $1.60 per share.

Geopolitical and production risks.

Operations in Russia and Ukraine, which accounted for 7% and 1% of net revenues respectively for the first nine months of 2026, carry risks including potential further impairment charges due to the conflict in Ukraine. The company also relies on two facilities in Kentucky and Colorado to produce most of its ZYN products for the U.S. market; a prolonged shutdown of these sites could limit its ability to meet demand.

Outlook.

Shareholders should monitor future reports for progress on assessing regulatory constraints regarding the sale of the Russian business and potential new impairment charges linked to the war in Ukraine. The company's financial reports remain the primary source of updates on these risks and financial performance.

Original sources

  1. financial data (XBRL)October 23, 2026SHA-256 of our archived copy 9d8a9d1a933f…
  2. 10-Q filing, October 23, 2026October 23, 2026SHA-256 of our archived copy 4c50e6899121…
  3. 8-K EX-99.1 filing, September 18, 2026September 18, 2026SHA-256 of our archived copy 7309503504f1…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards